extensive investigation of patients with mild elevations of serum amylase and/or lipase is ‘low yield’
;Michael F Byrne;Robert M Mitchell;Helen Stiffler;Paul S Jowell;Malcolm S Branch;Theodore N Pappas;Doug Tyler;John Baillie
indian journal of pharmacology2002Vol. 16pp. 849-854
139
byrne2002canadianextensive
Abstract
BACKGROUND: Serum amylase and lipase levels are widely used as markers of pancreatic inflammation. However, it would seem that mild elevations of amylase and lipase rarely predict significant pancreatic pathology. Pancreatic imaging tests are expensive. The gold standard, endoscopic retrograde cholangiopancreatography, carries risk of morbidity and mortality.